Table 2 Univariate and multivariate analyses of possible indicators related to 30-day survival

Gender (male/female)

0.359

0.078–1.661

0.190

Age (years)

1.026

0.985–1.069

0.220

LTS (cm)

1.160

1.039–1.294

0.008

1.233

1.061–1.434

0.006

BCLC (A + B/C)

2.086

0.800–5.438

0.133

Treatment at rupture

 Conservative (control)

–

–

–

–

–

–

 TAE/TACE

0.338

0.115–0.997

0.049

0.560

0.104–3.017

0.500

 Hepatectomy

0.229

0.065–0.805

0.022

0.811

0.141–4.655

0.814

Blood transfusion

0.500

0.154–1.627

0.250

Viral hepatitis (none/HBV + HCV)

0.739

0.233–2.692

0.710

Cirrhosis (no/yes)

1.892

0.512–6.988

0.339

AFP (≤400/> 400)

1.085

0.442–2.667

0.858

WBC (× 10⁹/L)

1.048

0.973–1.128

0.217

HB, (g/L)

0.975

0.956–0.994

0.009

0.985

0.956–1.014

0.301

PT (s)

1.359

1.142–1.616

0.001

0.934

0.707–1.233

0.630

ALB (g/L)

0.866

0.804–0.933

< 0.001

0.873

0.786–0.969

0.011

TBil (umol/L)

1.031

1.012–1.051

0.002

1.033

1.005–1.062

0.023

Na⁺ (mmol/L)

0.912

0.825–1.007

0.069

SCr (umol/L)

1.018

1.008–1.029

0.001

1.023

1.008–1.038

0.002